查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553584

栓塞預防設備市場規模、佔有率、趨勢分析報告：按產品、按應用、按地區、細分市場預測，2024-2030 年

Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters), By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

栓塞預防設備市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球栓塞防護設備市場規模預計將達到 10.9 億美元。

預計 2024 年至 2030 年該市場將以 8.7% 的複合年成長率擴張。心血管和神經血管疾病盛行率的上升以及微創疾病的日益普及正在推動市場成長。對技術先進的栓塞設備的需求不斷成長，醫療保健支出不斷增加，導致跨國公司投入大量資金和投資，刺激了全球醫療設備產業的研發。這一因素也促進了市場的成長。

另一方面，產品缺陷和召回可能會限制市場成長。支架治療報銷率低以及替代治療方法（例如使用藥物）的存在也可能阻礙市場開拓。然而，經導管主動脈瓣置換術（TAVR）病例數量增加等因素預計將支持市場擴張。

栓塞預防設備市場報告重點

  • 由於對這些設備的高需求，遠端過濾設備產業已成為最大的細分市場。
  • 由於神經病變的增加，神經血管疾病在應用中佔據最大佔有率
  • 2023年，北美引領全球栓塞防護設備市場，佔最大佔有率。
  • 微創手術的普及和對新技術不斷成長的需求正在推動該地區的主導地位。
  • 由於醫療基礎設施的迅速改善和龐大的目標人口基數，預計亞太地區的產業將在預測期內呈現快速成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章栓塞預防設備市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 栓塞預防設備市場分析工具
    • 波特的分析
    • PESTEL分析

第4章栓塞預防設備市場：依產品估算與趨勢分析

  • 細分儀表板
  • 栓塞預防設備市場：2023 年和 2030 年按產品分類的變化分析
  • 遠端封堵器
  • 近端封堵器
  • 遠端過濾器

第5章栓塞預防設備市場：依應用估算與趨勢分析

  • 細分儀表板
  • 栓塞預防設備市場：2023 年和 2030 年按應用分類的變化分析
  • 心血管疾病
  • 神經血管疾病
  • 周圍血管疾病

第6章栓塞預防設備市場：區域估計與趨勢分析

  • 2023 年及 2030 年栓塞預防設備市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation.
    • Abbott.
    • Medtronic
    • Cardinal Health.
    • Innovative Cardiovascular Solutions, LLC
    • Transverse Medical, Inc.
    • WL Gore &Associates, Inc.
簡介目錄
Product Code: GVR-2-68038-483-3

Embolic Protection Devices Market Growth & Trends:

The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.

On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.

Embolic Protection Devices Market Report Highlights:

  • Distal filter devices segment emerged as the largest segment owing to high demand for these devices
  • Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders
  • North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period
  • Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region
  • The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Embolic Protection Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Embolic Protection Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Embolic Protection Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Embolic Protection Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Distal Occlusion Devices
    • 4.3.1. Distal Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Proximal Occlusion Devices
    • 4.4.1. Proximal Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Distal Filters
    • 4.5.1. Ovarian Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Embolic Protection Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Embolic Protection Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular Diseases
    • 5.3.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Neurovascular Diseases
    • 5.4.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Peripheral Vascular Diseases
    • 5.5.1. Peripheral Vascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Embolic Protection Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Embolic Protection Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Boston Scientific Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Edwards Lifesciences Corporation.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Abbott.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Cardinal Health.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Innovative Cardiovascular Solutions, LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Transverse Medical, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. W. L. Gore & Associates, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives